Cargando…
Human adipose-derived mesenchymal stem cells for acute and sub-acute TBI
In the U.S., approximately 1.7 million people suffer traumatic brain injury each year, with many enduring long-term consequences and significant medical and rehabilitation costs. The primary injury causes physical damage to neurons, glia, fiber tracts and microvasculature, which is then followed by...
Autores principales: | Ruppert, Katherine A., Prabhakara, Karthik S., Toledano-Furman, Naama E., Udtha, Sanjna, Arceneaux, Austin Q., Park, Hyeonggeun, Dao, An, Cox, Charles S., Olson, Scott D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250455/ https://www.ncbi.nlm.nih.gov/pubmed/32453741 http://dx.doi.org/10.1371/journal.pone.0233263 |
Ejemplares similares
-
Correction: Human adipose-derived mesenchymal stem cells for acute and sub-acute TBI
por: Ruppert, Katherine A., et al.
Publicado: (2021) -
Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Modify Microglial Response and Improve Clinical Outcomes in Experimental Spinal Cord Injury
por: Ruppert, Katherine A., et al.
Publicado: (2018) -
High-resolution and differential analysis of rat microglial markers in traumatic brain injury: conventional flow cytometric and bioinformatics analysis
por: Toledano Furman, Naama, et al.
Publicado: (2020) -
Time dependent analysis of rat microglial surface markers in traumatic brain injury reveals dynamics of distinct cell subpopulations
por: Gottlieb, Assaf, et al.
Publicado: (2022) -
Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application
por: Caplan, Henry, et al.
Publicado: (2019)